Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerignoli, F.
Right arrow Articles by Giannini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerignoli, F.
Right arrow Articles by Giannini, G.
[Cancer Research 62, 1196-1204, February 15, 2002]
© 2002 American Association for Cancer Research


Tumor Biology

retSDR1, a Short-Chain Retinol Dehydrogenase/Reductase, Is Retinoic Acid-inducible and Frequently Deleted in Human Neuroblastoma Cell Lines1

Fabio Cerignoli, Xiaojia Guo, Beatrice Cardinali, Christian Rinaldi, Jessica Casaletto, Luigi Frati, Isabella Screpanti, Lorraine J. Gudas, Alberto Gulino, Carol J. Thiele3 and Giuseppe Giannini2,,3

Department of Experimental Medicine and Pathology, University La Sapienza, 00161 Rome, Italy,3 [L. F., I. S., A. G., G. G.]; Department of Experimental Medicine, University of L’Aquila, 67100 L’Aquila, Italy [F. C.]; Neuromed Institute, 86077 Pozzilli, Italy [C. R., L. F.]; Pasteur Institute Cenci-Bolognetti Foundation, 00161 Rome, Italy [I. S.]; Institute of Cell Biology, Consiglio Nazionale delle Ricerche (CNR), 00016 Monterotondo, Italy [B. C.]; Department of Pharmacology, Weill Medical College of Cornell University, New York, New York, 10021 [X. G., L. J. G.]; and Cellular and Molecular Biology Section, National Cancer Institute, NIH, Bethesda, Maryland,3 20892 [J. C., C. J. T.]

Vitamin A is required for a number of developmental processes and for the homeostatic maintenance of several adult differentiated tissues and organs. In human neuroblastoma (NB) cells as well as some other tumor types, pharmacological doses of retinoids are able to control growth and induce differentiation in vitro and in vivo. In a search for new genes that are regulated by retinoids and that contribute to the biological effects retinoids have on NB cells, we have isolated five differentially expressed transcripts. Here we report on the characterization of one of them (DD83.1) in NB cell lines. DD83.1 is identical to the human retSDR1, a short chain dehydrogenase/reductase that is thought to regenerate retinol from retinal in the visual cycle. Its expression is strongly, but differently, regulated by retinoids in NB cell lines, and it is widely expressed in human tissues, which suggests that it is involved in a more general retinol metabolic pathway. Both the retinoic acid-dependent and the exogenous expression of retSDR1 in SK-N-AS cells induce the accumulation of retinyl esters, which indicates that it is involved in generating storage forms of retinol in tissues exposed to physiological retinol concentrations. We also show that the human retSDR1 gene, which maps on chromosome 1p36.1, is contained in the DNA fragment deleted in many NB cell lines bearing MYCN amplification but is conserved in a cell line with a small 1p deletion and normal MYCN. Our observations suggest that retSDR1 is a novel regulator of vitamin A metabolism and that its frequent deletion in NB cells bearing MYCN amplification could compromise the sensitivity of those cells to retinol, thereby contributing to cancer development and progression.




This article has been cited by other articles:


Home page
J. Exp. Med.Home page
I. Szatmari, A. Pap, R. Ruhl, J.-X. Ma, P. A. Illarionov, G. S. Besra, E. Rajnavolgyi, B. Dezso, and L. Nagy
PPAR{gamma} controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells
J. Exp. Med., October 2, 2006; 203(10): 2351 - 2362.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
Y. Nishida, M. Yoshioka, and J. St-Amand
Regulation of hypothalamic gene expression by glucocorticoid: implications for energy homeostasis
Physiol Genomics, March 13, 2006; 25(1): 96 - 104.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Giannini, F. Cerignoli, M. Mellone, I. Massimi, C. Ambrosi, C. Rinaldi, C. Dominici, L. Frati, I. Screpanti, and A. Gulino
High Mobility Group A1 Is a Molecular Target for MYCN in Human Neuroblastoma
Cancer Res., September 15, 2005; 65(18): 8308 - 8316.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
F CERIGNOLI, C AMBROSI, M MELLONE, I ASSIMI, L. DI MARCOTULLIO, A GULINO, and G GIANNINI
HMGA Molecules in Neuroblastic Tumors
Ann. N.Y. Acad. Sci., December 1, 2004; 1028(1): 122 - 132.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. S. Williams, J. P. Mear, H.-C. Liang, S. S. Potter, B. J. Aronow, and M. C. Colbert
Large-scale reprogramming of cranial neural crest gene expression by retinoic acid exposure
Physiol Genomics, October 4, 2004; 19(2): 184 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Jette, P. W. Peterson, I. T. Sandoval, E. J. Manos, E. Hadley, C. M. Ireland, and D. A. Jones
The Tumor Suppressor Adenomatous Polyposis Coli and Caudal Related Homeodomain Protein Regulate Expression of Retinol Dehydrogenase L
J. Biol. Chem., August 13, 2004; 279(33): 34397 - 34405.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. I. Pass, Z. Liu, A. Wali, R. Bueno, S. Land, D. Lott, F. Siddiq, F. Lonardo, M. Carbone, and S. Draghici
Gene Expression Profiles Predict Survival and Progression of Pleural Mesothelioma
Clin. Cancer Res., February 1, 2004; 10(3): 849 - 859.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.